VCEL US Equity
Vericel CorpHealth Care · Biological Products, (No Diagnostic Substances) · CIK 887359 · FY ends Dec 31$43.57
-0.69 (-1.56%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 4.4M |
| % of shares out | 8.7% |
| Days to cover | 8.5 |
| Δ vs 2026-07-15 | -3.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 4,433,745 | -3.7% | 520,404 | 8.5 |
| 2026-07-15 | 4,603,010 | -6.3% | 508,424 | 9.1 |
| 2026-06-30 | 4,913,692 | -7.1% | 922,708 | 5.3 |
| 2026-06-15 | 5,290,119 | +4.2% | 566,581 | 9.3 |
| 2026-05-29 | 5,075,540 | -4.9% | 547,239 | 9.3 |
| 2026-05-15 | 5,335,727 | +7.2% | 706,965 | 7.5 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
